Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Avecho Biotechnology (ASX:AVE) Shares Jump Following Clinical Trial Milestone

Avecho Biotechnology Ltd (ASX:AVE) shares climbed 8.33% to AUD 0.013 during the morning session on 21 May 2026 after the company announced the completion of a key stage in its pivotal Phase III insomnia clinical trial. Despite the latest move higher, the stock remains …

Aditi Sarkar | 21 May 2026

Noxopharm (ASX:NOX) Moves Ahead with Key Biotechnology Initiative

Noxopharm Ltd (ASX:NOX) has announced that data connected to its Sofra technology platform will be presented at a major international scientific conference later this year, highlighting the company’s ongoing work in RNA therapeutics and vaccine-related applications.

Aditi Sarkar | 20 May 2026

Vitasora Health (ASX:VHL) Accelerates vCare Rollout as Patient Enrolment Momentum Builds

Vitasora Health is accelerating its vCare rollout as patient enrolment momentum builds, according to Small Caps coverage on 18 May 2026. The rollout includes remote patient monitoring (RPM) live tests, with the company targeting annual savings of $1.7-1.8 million and more than 550 monthly …

Aditi Sarkar | 20 May 2026

Patrys (ASX:PAB) Shares Climb Following Key Clinical Trial Milestone

Patrys Limited (ASX:PAB) shares traded higher during the afternoon session on 20 May 2026 after the company announced key appointments supporting the advancement of its RLS-2202 program toward Phase 1 clinical development.

Aditi Sarkar | 20 May 2026

Vitura Health (ASX:VIT) in Focus After Former CEO Commences Legal Proceedings

Vitura Health Limited (ASX:VIT) has confirmed that its former Chief Executive Officer, Mr Geoff Cockerill, has initiated legal proceedings against the company in the Federal Circuit and Family Court of Australia.

Aditi Sarkar | 20 May 2026

Optiscan Imaging (ASX:OIL) Gains After Funding Update Supports R&D Pipeline

Optiscan Imaging Ltd (ASX:OIL) shares traded 2.33% higher to AUD 0.11 during the afternoon session on 20 May 2026 after the company announced it had received a FY25Research and Development(R&D) tax refund worth AUD 1.69 million. The latest funding update appeared to draw investor …

Aditi Sarkar | 20 May 2026

Island Pharmaceuticals Strengthens US Biodefence Strategy for Galidesivir Development

Island Pharmaceuticals is reinforcing its US biodefence strategy with new adviser appointments, expanded MC2 roles and continued progress for its Galidesivir program toward FDA Animal Rule trials, according to Small Caps coverage on 19 May 2026.

Aditi Sarkar | 20 May 2026

Monash IVF (ASX:MVF) Strengthens Clinical Leadership With First Chief Medical Officer Appointment

Monash IVF Group is reinforcing its clinical leadership with the appointment of fertility specialist Fleur Cattrall as its inaugural Chief Medical Officer, the company announced. The move creates a new executive-level medical leadership role aimed at strengthening clinical governance, patient care and operational performance …

Aditi Sarkar | 20 May 2026

BCAL (ASX:BDX) Diagnostics Expands National Access to Early Cancer Detection Blood Tests

BCAL Diagnostics is expanding national access to its early cancer detection blood tests by integrating GP referral forms within major Australian clinical software platforms, according to Small Caps coverage on 19 May 2026. The company is also launching the EarlyDetection telehealth service to support …

Aditi Sarkar | 20 May 2026

Algorae Pharmaceuticals (ASX:1AI) Expands AI Drug Discovery Pipeline With AOS2 Program

Algorae Pharmaceuticals has expanded its AI drug combination pipeline with the AOS2 program, which features 18 anchors and more than 478,000 synergy predictions across cell lines, according to Small Caps coverage on 18 May 2026.

Aditi Sarkar | 20 May 2026
Support

Hi! How can we help you today?

Loading…